Growth Metrics

BioNexus Gene Lab (BGLC) Deferred Taxes (2022 - 2023)

BioNexus Gene Lab recorded quarterly Deferred Taxes of $15990.0 in Q2 2023, up 886.43% quarter-over-quarter from $1621.0 in Q2 2022, and up 886.43% year-over-year from $1621.0 in Q2 2022.

BioNexus Gene Lab's Deferred Taxes history runs 2 years deep, the most recent figure standing at $15990.0 for Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Linde 230.79 Bn 226.84 Bn 4.26 Bn 8.00 Mn
2 Chemical & Mining Co Of Chile 127.66 Bn 124.93 Bn 778.60 Mn -
3 Sherwin Williams 72.51 Bn 72.30 Bn 2.78 Bn -3.20 Mn
4 Ecolab 70.96 Bn 70.34 Bn 1.85 Bn 23.70 Mn
5 Air Products & Chemicals 62.15 Bn 63.70 Bn 987.40 Mn 47.40 Mn
6 Ppg Industries 25.04 Bn 23.57 Bn 1.66 Bn 11.00 Mn
7 LyondellBasell Industries 21.62 Bn 21.73 Bn 701.00 Mn 20.00 Mn
8 Albemarle 20.26 Bn 19.42 Bn 500.97 Mn -1.01 Mn
9 DuPont de Nemours 19.45 Bn 19.56 Bn 602.00 Mn -12.00 Mn
10 BioNexus Gene Lab 5.34 Mn 1.38 Mn -790.00 -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 15,990.00
Jun 30, 2022 1,621.00